Literature DB >> 27408374

Plasmablastic Lymphoma of Small Intestine: A Rare Case Report with Review of Literature.

Rachna Khera1, Faiq Ahmed1, Sudha S Murthy1, Krishna Mohan Mallavarapu2.   

Abstract

Plasmablastic lymphoma (PBL) is a rare aggressive neoplasm characterized by diffuse proliferation of large neoplastic cells with plasma cell immunophenotype. Cell of origin of PBL is believed to be a postgerminal center B-lymphocyte or plasmablast. The malignant cells in PBL usually do not express CD20 (B cell marker) but do express markers of plasmacytic differentiation, such as CD38, CD138, or MUM1/IRF4, akin to plasma cell myeloma (PCM). PBL though originally described in the oral cavity, has now been found to occur in extraoral locations as well. Small intestine as a site of PBL has been described very rarely. PBL remains a diagnostic challenge given its overlapping morphologic and immunophenotypic features with other high grade lymphomas and PCM. We report a rare case of PBL of small intestine in a 48 years old HIV infected male patient. To the best of our knowledge this represents sixth case in the literature described in this location. An unusual rare pattern of CD138 positivity by IHC is also reported along with extensive review of literature of PBL in extraoral locations.

Entities:  

Year:  2015        PMID: 27408374      PMCID: PMC4925508          DOI: 10.1007/s12288-015-0549-7

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  16 in total

1.  Surgical resection of small bowel plasmablastic lymphoma for chronic bleeding.

Authors:  Victor J Olivas; Mentor Ahmeti; Luis De Las Casas; Brian R Davis
Journal:  Am Surg       Date:  2011-07       Impact factor: 0.688

2.  Plasmablastic lymphoma in HIV-positive patients: an aggressive Epstein-Barr virus-associated extramedullary plasmacytic neoplasm.

Authors:  Henry Y Dong; David T Scadden; Laurence de Leval; Zuoqin Tang; Peter G Isaacson; Nancy L Harris
Journal:  Am J Surg Pathol       Date:  2005-12       Impact factor: 6.394

Review 3.  Plasmablastic lymphoma of the stomach.

Authors:  Ahmed Sawas; Owen A O'Connor
Journal:  Clin Adv Hematol Oncol       Date:  2012-07

4.  Extra-oral plasmablastic lymphoma: report of a case and review of literature.

Authors:  Fabio Tavora; Luis F Gonzalez-Cuyar; Chen-Chih J Sun; Allen Burke; X Frank Zhao
Journal:  Hum Pathol       Date:  2006-07-07       Impact factor: 3.466

5.  Clinical and pathological differences between human immunodeficiency virus-positive and human immunodeficiency virus-negative patients with plasmablastic lymphoma.

Authors:  Jorge J Castillo; Eric S Winer; Dariusz Stachurski; Kimberly Perez; Melhem Jabbour; Cannon Milani; Gerald Colvin; James N Butera
Journal:  Leuk Lymphoma       Date:  2010-10-04

6.  A case report with plasmablastic lymphoma of the jejunum.

Authors:  Jae Myung Cha; Joung Il Lee; Kwang Ro Joo; Sung Won Jung; Hyun Phil Shin; Jae Jin Lee; Gyo Young Kim
Journal:  J Korean Med Sci       Date:  2010-02-18       Impact factor: 2.153

7.  Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection.

Authors:  H J Delecluse; I Anagnostopoulos; F Dallenbach; M Hummel; T Marafioti; U Schneider; D Huhn; A Schmidt-Westhausen; P A Reichart; U Gross; H Stein
Journal:  Blood       Date:  1997-02-15       Impact factor: 22.113

8.  Soft-tissue masses as presentation of non-Hodgkin's lymphoma in AIDS patients.

Authors:  Marcelo Corti; María Florencia Villafañe; Alicia Bistmans; Ana Campitelli; Marina Narbaitz
Journal:  An Bras Dermatol       Date:  2013 Jul-Aug       Impact factor: 1.896

Review 9.  HIV-associated plasmablastic lymphoma: lessons learned from 112 published cases.

Authors:  Jorge Castillo; Liron Pantanowitz; Bruce J Dezube
Journal:  Am J Hematol       Date:  2008-10       Impact factor: 10.047

10.  Plasmablastic Lymphoma presenting as small intestinal polyposis: A case-report.

Authors:  A Bahari; M Jahantigh; A Mashhadi; Z Bari; Ar Bari
Journal:  Iran Red Crescent Med J       Date:  2012-10-30       Impact factor: 0.611

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.